$Novavax (NVAX.US)$ surged after the vaccine maker said it had struck a licensing deal worth up to $1.4 billion with $Sanofi (SNY.US)$. The firm also posted a quarterly loss $1.05 a share Friday. The company also lifted its going-concern notice that was issued over a year ago.
$诺瓦瓦克斯医药 (NVAX.US)$ 在这家疫苗生产商表示已与之达成价值高达14亿美元的许可协议后，该疫苗飙升 $赛诺菲安万特 (SNY.US)$。该公司周五还公布了每股1.05美元的季度亏损。该公司还取消了一年多前发布的持续经营通知。
The company said overnight that it would jointly commercialize its Covid-19 vaccine worldwide with Sanofi. The French healthcare company will get a sole license to combine the treatment with its flu vaccine.
该公司隔夜表示，将与赛诺菲共同在全球范围内将其Covid-19疫苗商业化。这家法国医疗保健公司将获得将该疗法与流感疫苗结合的唯一许可。
Sanofi will take a minority stake of less than 5% in Novavax.
赛诺菲将收购Novavax不到5％的少数股权。